Impact of electronic cigarette ever use on lung function in adults aged 45–85: a cross-sectional analysis from the Canadian Longitudinal Study on Aging
Open Access
Abstract
Objective: To describe the sociodemographic characteristics associated with e-cigarette ever use and to examine the impact of e-cigarette ever use on lung function impairment in an ageing population. Design: A cross-sectional analysis of data from the Canadian Longitudinal Study on Aging. Setting: A national stratified sample of 44 817 adults living in Canadian provinces. Participants: Respondents included participants aged 45–85 and residing in the community in Canadian provinces. Outcome measures: The Global Lung Function Initiative normative values for forced expiratory volume in the first second (FEV 1 ), forced vital capacity (FVC), forced expiratory ratio (FEV 1 /FVC) appropriate for age, sex, height and ethnicity were used to interpret the severity of lung function impairment. Multinomial logistic regression analysis was used to examine the impact of e-cigarette ever use on obstructive and restrictive lung function impairment. Results: The prevalence of e-cigarette ever use was 6.5% and varied by sociodemographic factors including higher prevalence among individuals younger than 65 years, those with lower education attainment and those with lower annual household income. E-cigarette ever use was associated with 2.10 (95% CI 1.57 to 2.08) times higher odds of obstructive lung function impairment after adjusting for conventional cigarette smoking and other covariates. Individuals with exposure to e-cigarette ever use and 15 or more pack-years had 7.43 (95% CI 5.30 to 10.38) times higher odds for obstructive lung function impairment when compared with non-smokers and non-e-cigarette users after adjusting for covariates. Smokers with 15 or more pack-years had higher odds of restrictive lung function impairment irrespective of e-cigarette ever use. Conclusions: Ever use of e-cigarettes was found to be associated with obstructive lung function impairment after adjusting for covariates, suggesting that e-cigarette use may be adding to the respiratory and other chronic disease burden in the population.Keywords
Funding Information
- Canadian Institutes of Health Research (LSA 94473)
This publication has 45 references indexed in Scilit:
- Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumersInternational Journal of Hygiene and Environmental Health, 2014
- Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung functionInhalation Toxicology, 2013
- Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary diseaseAnnals of the New York Academy of Sciences, 2012
- Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEuropean Respiratory Journal, 2012
- Short-term Pulmonary Effects of Using an Electronic CigaretteChest, 2012
- Electronic cigarettes: a survey of usersBMC Public Health, 2010
- Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trialTobacco Control, 2010
- The Canadian Longitudinal Study on Aging (CLSA)Canadian Journal on Aging / La Revue canadienne du vieillissement, 2009
- Tobacco harm reduction: How rational public policy could transform a pandemicInternational Journal of Drug Policy, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005